Articles tagged as 'DataScience'

12 results

Current safety concerns with HPV vaccination
Using adverse event cluster analysis UMC and the Danish pharmacovigilance centre have researched the extent of safety concerns associated with HPV vaccinations.

EHDEN consortium seeking better value from data
Despite great progress, real-world data that could be better exploited to research and improve healthcare systems, services and treatments, for the benefit of patients.

Big data and signal detection at ISoP
ISoP's 15th annual meeting in Prague, Czech Republic, in October 2015 had an unusual theme – Cubism in Pharmacovigilance, inspired by the Czech cubism movement in the early 1900s.

Automatic for the people
Deep learning shows promise removing personal identifiers from case reports, according to new work presented by UMC researchers.

Found in space – New method reveals related drug and reaction terms
Could natural language processing unlock powerful new methods in pharmacovigilance science? See how a journey through space could lead to a new dimension in case report analysis.

vigiGroup in action – new method identifies groups of related reports
See how UMC’s new clustering algorithm identifies groups of related reports in our new explainer animation.

UMC breaks ground in automated coding for safety reports
A new study highlights the gains to be made in time, quality, and consistency from using UMC’s coding engine WHODrug Koda to automate drug coding in post-marketing surveillance.

Fruitful start for EHDEN-powered signal discovery
In a weeklong groundbreaking study-a-thon with the IMI EHDEN consortium, UMC researchers found longitudinal health data could boost preliminary analysis of drug-event combinations.

Unmasking data in the COVID-19 vaccine era – New podcast episode
What are the implications for signal detection when new approaches to reporting create greater data streams than have ever been present for older medicinal products?

Expanding sources of evidence for better signal detection – New podcast out now
In this digital age, can pharmacovigilance experts leverage on new types of data to find evidence for signals? Listen to the latest Drug Safety Matters podcast to find out.

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more